Israel Englander Sellas Life Sciences Group, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 150,448 shares of SLS stock, worth $189,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,448Holding current value
$189,564% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
4.37MCall Options Held
3.28MPut Options Held
56.3K-
Vanguard Group Inc Valley Forge, PA1.79MShares$2.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA517KShares$651,4300.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$542,2630.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$388,6673.71% of portfolio
-
Opus Capital Group, LLC221KShares$278,4600.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $25.9M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...